MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 274 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 1.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,428,816 | -19.6% | 5,100 | -23.4% | 0.01% | -41.7% |
| Q1 2024 | $1,777,952 | +159.5% | 6,658 | +41.9% | 0.01% | +71.4% |
| Q3 2023 | $685,220 | -7.8% | 4,692 | +45.8% | 0.01% | -22.2% |
| Q2 2023 | $743,589 | +23825.0% | 3,219 | -74.9% | 0.01% | -81.2% |
| Q1 2023 | $3,108 | +26.8% | 12,829 | +51.9% | 0.05% | 0.0% |
| Q4 2022 | $2,451 | -99.5% | 8,445 | +7.9% | 0.05% | +336.4% |
| Q3 2022 | $509,000 | -9.1% | 7,828 | +0.1% | 0.01% | -26.7% |
| Q2 2022 | $560,000 | -22.5% | 7,817 | -8.4% | 0.02% | +25.0% |
| Q4 2021 | $723,000 | +42.0% | 8,536 | +52.7% | 0.01% | -47.8% |
| Q4 2019 | $509,000 | – | 5,589 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |